The "Continuous Review" Paradigm (ICH Q10)
Traditional APQRs are reactive—they analyze what happened last year. **ICH Q10** and **FDA Guidance on Process Validation** now emphasize a *lifecycle approach*. QA Stack bridges this gap by enabling Stage 3 Continued Process Verification (CPV) as an automated, daily operational reality.
Operational Impact Benchmark
The SPC Engine: Precision at Scale.
Our analytics engine doesn't just store data—it applies rigorous statistical methodologies to ensure your manufacturing process stays within validated boundaries.
Capability Indices (Cpk/Ppk)
Automatic calculation of process potential and actual capability. Spot trends where the process is stable but drifting toward specifications limits.
Control Charts (X-Bar, R, S)
Real-time generation of Shewhart control charts with automated Western Electric rule violation flagging. Identify "Special Cause" variation instantly.
OOS & OOT Correlation
Correlate Out-of-Specification and Out-of-Trend results with investigation metadata to identify systemic failures across product families.
Stability Trend Analysis
Ingest stability testing data from LIMS to model product shelf-life and degradation kinetics (Arrhenius) across different storage conditions.
Yield Variance Engine
Analyze yield variances by site, manufacturing line, or operator to identify efficiency gaps and best practices for standardization.
Environmental Trending
Link Cleanroom EM data directly to batch performance to evaluate the impact of environmental conditions on product quality.
Operational Data Mesh
100% GxP Data Hydration.
A "Living APQR" is only as good as its data integrity. QA Stack maintains an immutable data thread from the shop floor to the final report, ensuring every chart and graph is fully traceable to its original raw data point.
The "Living APQR" in Action
Preventive Change Control
Analytics identified a 5% drift in yield on Line 4. Investigation revealed a worn gasket before a deviation occurred. Change control was initiated proactively.
Multi-Site Standardization
Corporate QA compared Cpk results for a blockbuster drug across 3 sites. Site B was 20% more capable. Best practices were exported to Sites A and C.
Vendor Risk Evaluation
APQR data correlated a spike in dissolution deviations with a specific excipient lot. The vendor was audited and put on a quality watch-list.